276 related articles for article (PubMed ID: 9188842)
1. Concomitant downregulation of IgH 3' enhancer activity and c-myc expression in a plasmacytoma x fibroblast environment: implications for dysregulation of translocated c-myc.
Thøger Andersen AS; Jensen AW; Grant P; Arulampalam V; Pettersson S; Junker S
Mol Immunol; 1997 Feb; 34(2):97-107. PubMed ID: 9188842
[TBL] [Abstract][Full Text] [Related]
2. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
3. Aberrant regulation of the IgH 3' enhancer by c-myc in plasmacytoma cells.
Arulampalam V; Grant P; Poellinger L; Pettersson S
Mol Immunol; 1995 Dec; 32(17-18):1369-75. PubMed ID: 8643106
[TBL] [Abstract][Full Text] [Related]
4. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
5. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
6. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes.
Madisen L; Krumm A; Hebbes TR; Groudine M
Mol Cell Biol; 1998 Nov; 18(11):6281-92. PubMed ID: 9774645
[TBL] [Abstract][Full Text] [Related]
7. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus.
Pettersson S; Cook GP; Brüggemann M; Williams GT; Neuberger MS
Nature; 1990 Mar; 344(6262):165-8. PubMed ID: 2106628
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability in B-cells and diversity of recombinations that activate c-myc.
Janz S; Jones GM; Müller JR; Potter M
Curr Top Microbiol Immunol; 1995; 194():373-80. PubMed ID: 7895512
[TBL] [Abstract][Full Text] [Related]
9. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
Jain VK; Judde JG; Max EE; Magrath IT
J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
[TBL] [Abstract][Full Text] [Related]
10. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region.
Gostissa M; Yan CT; Bianco JM; Cogné M; Pinaud E; Alt FW
Nature; 2009 Dec; 462(7274):803-7. PubMed ID: 20010689
[TBL] [Abstract][Full Text] [Related]
11. Discovery platform for inhibitors of IgH gene enhancer activity.
Dolloff NG
Cancer Biol Ther; 2019; 20(4):571-581. PubMed ID: 30481117
[TBL] [Abstract][Full Text] [Related]
12. Recombination of the c-myc gene with IgH enhancer-S mu sequences in a murine plasmacytoma (DCPC21) without visible chromosomal translocations.
Ohno S; Migita S; Murakami S
Curr Top Microbiol Immunol; 1990; 166():267-78. PubMed ID: 2127395
[No Abstract] [Full Text] [Related]
13. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
Yan Y; Park SS; Janz S; Eckhardt LA
Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
[TBL] [Abstract][Full Text] [Related]
14. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
Wang J; Boxer LM
J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
[TBL] [Abstract][Full Text] [Related]
15. Mouse Models of
Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y
Front Immunol; 2020; 11():1564. PubMed ID: 32793219
[TBL] [Abstract][Full Text] [Related]
16. The c-myc oncogene is translocated to the involved chromosome 12 in mouse plasmacytoma.
Erikson J; Miller DA; Miller OJ; Abcarian PW; Skurla RM; Mushinski JF; Croce CM
Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4212-6. PubMed ID: 3923490
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms promoting translocations in editing and switching peripheral B cells.
Wang JH; Gostissa M; Yan CT; Goff P; Hickernell T; Hansen E; Difilippantonio S; Wesemann DR; Zarrin AA; Rajewsky K; Nussenzweig A; Alt FW
Nature; 2009 Jul; 460(7252):231-6. PubMed ID: 19587764
[TBL] [Abstract][Full Text] [Related]
18. Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC.
Bützler C; Zou X; Popov AV; Brüggemann M
Oncogene; 1997 Mar; 14(11):1383-8. PubMed ID: 9178899
[TBL] [Abstract][Full Text] [Related]
19. Activation of the c-myc oncogene by the immunoglobulin heavy-chain gene enhancer after multiple switch region-mediated chromosome rearrangements in a murine plasmacytoma.
Fahrlander PD; Sümegi J; Yang JQ; Wiener F; Marcu KB; Klein G
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3746-50. PubMed ID: 2987943
[TBL] [Abstract][Full Text] [Related]
20. Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene.
Webb E; Adams JM; Cory S
Nature; 1984 Dec 20-1985 Jan 2; 312(5996):777-9. PubMed ID: 6440031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]